Total Payments
$883.46
2022 Payments
$15.30
Companies
12
Transactions
28
Medicare Patients
465
Medicare Billing
$36,222
Payment Breakdown by Category
Food & Beverage$806.47 (91.3%)
Education$76.99 (8.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $806.47 | 27 | 91.3% |
| Education | $76.99 | 1 | 8.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $234.69 | 8 | $0 (2022) |
| Janssen Biotech, Inc. | $198.23 | 7 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $190.45 | 2 | $0 (2018) |
| Lilly USA, LLC | $45.58 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $44.72 | 2 | $0 (2020) |
| Amgen Inc. | $31.53 | 1 | $0 (2019) |
| PFIZER INC. | $25.81 | 1 | $0 (2018) |
| LEO Pharma Inc. | $24.89 | 1 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $24.75 | 1 | $0 (2017) |
| DUSA Pharmaceuticals, Inc. | $24.06 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $15.30 | 1 | ABBVIE INC. ($15.30) |
| 2021 | $31.51 | 2 | Janssen Biotech, Inc. ($16.27) |
| 2020 | $58.22 | 3 | Lilly USA, LLC ($22.05) |
| 2019 | $238.25 | 11 | AbbVie, Inc. ($69.68) |
| 2018 | $150.04 | 3 | Janssen Scientific Affairs, LLC ($97.53) |
| 2017 | $390.14 | 8 | Janssen Biotech, Inc. ($130.81) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2022 | ABBVIE INC. | RINVOQ (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Immunology | ||||||
| 01/14/2021 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: IMMUNOLOGY | ||||||
| 02/19/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Immunology | ||||||
| 12/18/2019 | Amgen Inc. | Otezla (Biological) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Inflammation | ||||||
| 11/13/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Immunology | ||||||
| 11/06/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Immunology | ||||||
| 10/23/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Immunology | ||||||
| 10/16/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Immunology | ||||||
| 08/21/2019 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Dermatology | ||||||
| 08/07/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Immunology | ||||||
| 07/24/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: DERMATOLOGY | ||||||
| 06/05/2019 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: DERMATOLOGY | ||||||
| 05/29/2019 | DUSA Pharmaceuticals, Inc. | LEVULAN KERASTICK (Drug), BLU-U | Food and Beverage | Cash or cash equivalent | $24.06 | General |
| Category: Dermatology | ||||||
| 04/10/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Immunology | ||||||
| 12/13/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: DERMATOLOGY | ||||||
| 04/26/2018 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Immunology | ||||||
| 01/19/2018 | Janssen Scientific Affairs, LLC | Tremfya (Drug), STELARA | Food and Beverage | In-kind items and services | $97.53 | General |
| Category: Immunology | ||||||
| 12/14/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $76.99 | General |
| Category: Immunology | ||||||
| 09/28/2017 | Janssen Scientific Affairs, LLC | GUSELKUMAB (Biological) | Food and Beverage | In-kind items and services | $92.92 | General |
| Category: R&D Compound | ||||||
| 09/07/2017 | Janssen Biotech, Inc. | GUSELKUMAB (Biological) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: R&D Compound | ||||||
| 04/27/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Immunology | ||||||
| 04/20/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 141 | 239 | $30,244 | $7,886 |
| 2020 | 10 | 324 | 689 | $84,353 | $28,336 |
Total Patients
465
Total Services
928
Medicare Billing
$36,222
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 60 | $11,906 | $2,928 | 24.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 28 | 31 | $8,040 | $1,998 | 24.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 18 | 19 | $4,511 | $1,254 | 27.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 25 | 29 | $4,289 | $1,133 | 26.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 18 | 100 | $1,498 | $571.38 | 38.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 77 | 115 | $27,030 | $9,249 | 34.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 46 | 65 | $16,308 | $6,033 | 37.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 41 | 47 | $10,541 | $3,096 | 29.4% |
| 17000 | Destruction of skin growth | Office | 2020 | 47 | 75 | $10,835 | $2,787 | 25.7% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 13 | 18 | $6,328 | $2,457 | 38.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 36 | $5,849 | $2,063 | 35.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 40 | 278 | $3,780 | $1,459 | 38.6% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 14 | 15 | $1,782 | $702.90 | 39.4% |
| 11900 | Injection of up to 7 skin growths | Office | 2020 | 11 | 15 | $1,827 | $460.95 | 25.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 11 | 25 | $73.26 | $27.94 | 38.1% |
About Dr. Deidre Buddin, M.D
Dr. Deidre Buddin, M.D is a Dermatopathology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669465951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deidre Buddin, M.D has received a total of $883.46 in payments from pharmaceutical and medical device companies, with $15.30 received in 2022. These payments were reported across 28 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($806.47).
As a Medicare-enrolled provider, Buddin has provided services to 465 Medicare beneficiaries, totaling 928 services with total Medicare billing of $36,222. Data is available for 2 years (2020–2021), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location La Jolla, CA
- Active Since 08/23/2005
- Last Updated 07/13/2010
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1669465951
Products in Payments
- Humira (Biological) $188.34
- Tremfya (Drug) $148.68
- GUSELKUMAB (Biological) $119.85
- STELARA (Biological) $103.88
- TALTZ (Drug) $45.58
- COSENTYX (Biological) $44.72
- Otezla (Biological) $31.53
- SKYRIZI (Biological) $31.05
- EUCRISA (Drug) $25.81
- ENSTILAR (Drug) $24.89
- JUBLIA EFINACONAZOLE (Drug) $24.75
- LEVULAN KERASTICK (Drug) $24.06
- TREMFYA (Drug) $16.27
- Ameluz (Drug) $15.75
- RINVOQ (Biological) $15.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.